Cannabis Bioscience International Holdings, Inc. (CBIH) Other Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Other Operating Expenses across 5 years of filings, most recently posting $62139.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 1.68% year-over-year to $62139.0; the TTM figure through Feb 2026 stood at $414264.0 (up 7.44% YoY), while the FY2025 annual figure was $516557.0, up 8.33% from the prior year.
• Other Operating Expenses came in at $62139.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $96270.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $241961.0 in Q1 2023 to a low of $56261.0 in Q3 2025.
• Average Other Operating Expenses over 5 years is $134840.0, with a median of $122386.0 recorded in 2023.
• The largest YoY upside for Other Operating Expenses was 190.92% in 2025 against a maximum downside of 70.14% in 2025.
• Over 5 years, Other Operating Expenses stood at $218680.0 in 2022, then slumped by 52.74% to $103354.0 in 2023, then slumped by 34.78% to $67408.0 in 2024, then soared by 42.82% to $96270.0 in 2025, then tumbled by 35.45% to $62139.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $62139.0 in Q1 2026, $96270.0 in Q4 2025, and $56261.0 in Q3 2025.